← All trials
NCT04473690
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 28, 2020
- Primary completion
- May 6, 2021
- Completion date
- Mar 23, 2022
- First posted
- Jul 16, 2020
- Last posted
- Dec 14, 2020
- Enrollment
- 180
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Kentucky BioProcessing, Inc.Lead sponsor
- Kentucky BioProcessing, Inc.Study director
- ICONOverall official - principal investigator
- PMG ResearchOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.